The Latest Cardiac and Vascular News
BERLIN & BOSTON–(BUSINESS WIRE)–OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced the appointment of Christian Schetter, Ph.D., as an independent Board Member. Christian has over 20 years’ industry experience across the life sciences sector, and most […]
OSLO–(BUSINESS WIRE)–CardioMech AS announced today that it has closed on a convertible note financing of $2.5 million, which was significantly oversubscribed. The note included investments from experienced angel investors in interventional cardiology and structural heart disease. “This financing milestone demonstrates the rapid acceleration of the development of CardioMech’s transcatheter mitral valve repair technology. […]
BORDEAUX, France–(BUSINESS WIRE)–FineHeart today announced that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. FineHeart’s technology, the ICOMS (Implantable Cardiac Output Management System), is dedicated to the treatment of severe heart […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, announced today that it has raised an undisclosed amount in a new financing round. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc., and included participation from […]
SANTA CLARA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today announced that Laura Francis has joined its Board of Directors and will serve as Chairperson of Shockwave’s Audit Committee. Ms. Francis currently […]
BURLINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and […]
TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, February 19, […]
Toledo, Ohio, February 5, 2019 – VentureMed Group, Inc., a privately-held medical device company that develops and markets the FLEX Vessel Prep™ System to treat peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced today that J. Robert Paulson, Jr., has been appointed president and chief […]
MARLBOROUGH, Mass., Feb. 6, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.561 billion during the fourth quarter of 2018. This represents growth of 6.3 percent on a reported basis, 8.2 percent on an operational1 basis and 7.0 percent on an organic2 basis, all compared to the prior year period. The company reported […]
KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–CathWorks announced the completion of a $30 million Series C financing round led by Deerfield Management. Jim Corbett, CathWorks CEO, stated, “We are delighted to have such a notable investor leading this round and for the continued full participation of our existing syndicate of […]
